What Researchers Did
The present study analysed the effects of 20 hyperbaric oxygen therapy (HBOT) sessions on oxidative stress, inflammation biomarkers, and growth factors in patients with chronic diabetic wounds.
What They Found
Researchers found that pro-inflammatory mediators (TNF-α, IL-1β) and oxidative stress biomarkers (e.g., MDA, protein carbonyls) progressively decreased throughout the 20 HBOT sessions. Plasma levels of growth factors (PDFG, TGF-β, HIF-1α) increased due to HBOT, indicating a favourable environment for wound healing.
What This Means for Canadian Patients
For Canadian patients with chronic diabetic wounds, these findings suggest that hyperbaric oxygen therapy could be a beneficial treatment to reduce inflammation and oxidative stress, promoting better wound healing. This therapy may offer an improved approach to managing persistent diabetic ulcers, potentially leading to faster recovery and reduced complications.
Canadian Relevance
This study has no direct Canadian connection, as it was not conducted in Canada nor involved Canadian participants or institutions.
Study Limitations
A potential limitation is the absence of a true placebo control group for the hyperbaric oxygen therapy intervention.